Received: from PAZP264CA0083.FRAP264.PROD.OUTLOOK.COM (2603:10a6:102:1fa::10) by PAWPR02MB9973.eurprd02.prod.outlook.com (2603:10a6:102:2ec::14) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.23; Wed, 14 Oct 2026 06:27:58 +0000 Received: from AM7PEPF00000054.EURPRD83.prod.outlook.com (2603:10a6:102:1fa:cafe::45) by PAZP264CA0083.outlook.office365.com (2603:10a6:102:1fa::10) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.522.4 via Frontend Transport; Wed, 14 Oct 2026 06:27:57 +0000 Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by AM7PEPF00000054.mail.protection.outlook.com (10.167.242.40) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.546.0 via Frontend Transport; Wed, 14 Oct 2026 06:27:57 +0000 Received: from PAWPR02MB9973.eurprd02.prod.outlook.com (2603:10a6:102:2ec::14) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Wed, 14 Oct 2026 06:28:02 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104]) by GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104%5]) with mapi id 15.21.0522.012; Wed, 14 Oct 2026 06:27:55 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com (2603:10a6:150:351::5) by PAVPR02MB9596.eurprd02.prod.outlook.com (2603:10a6:102:30f::11) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.23; Wed, 14 Oct 2026 06:27:55 +0000 Received: from DB6PR07CU003.outbound.protection.outlook.com (40.93.64.91) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Wed, 14 Oct 2026 06:27:57 +0000 From: "Kommunikatsioon - RA" To: =?utf-8?Q?K=C3=A4rolin_Jenas_-_RA?= References: In-Reply-To: Subject: =?utf-8?Q?Ed:_Apteekide_tulevik_ja_proviis?= =?utf-8?Q?orite_j=C3=A4relkasv_Viljandimaal?= Date: Wed, 14 Oct 2026 09:27:55 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_02A3_01DD5CA6.CA399200" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQF2jbIkrq26/q9sMJ1hFutUWTFXQgGGhbi8Aff2xro= Authentication-Results: mx.microsoft.com 1; spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 14 Oct 2026 06:27:57.9484 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: aeff8d5e-85bb-46b1-8ca3-08df29bc49d9 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GV2PR02MB11921:EE_|PAVPR02MB9596:EE_|AM7PEPF00000054:EE_|PAWPR02MB9973:EE_|VI1PR02MB5024:EE_ X-MS-Exchange-Organization-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: aeff8d5e-85bb-46b1-8ca3-08df29bc49d9 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|82310400026|23010399003|366016|39142699007|35042699022|31052699007|18002099003|22082099003|55112099003|260925021911599003|260925022911599003|260925021311599003|10067099003|8096899003|11063799006|261009223027099003|4143699003|56012099006|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(82310400026)(23010399003)(366016)(39142699007)(35042699022)(31052699007)(18002099003)(22082099003)(55112099003)(260925021911599003)(260925022911599003)(260925021311599003)(10067099003)(8096899003)(11063799006)(261009223027099003)(4143699003)(56012099006)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 14 Oct 2026 06:27:57.9230 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: aeff8d5e-85bb-46b1-8ca3-08df29bc49d9 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAVPR02MB9596 X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAWPR02MB9973 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.8772475 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0496.018 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalclientipaddress: 146.255.180.216 x-ms-exchange-organization-originalserveripaddress: 10.167.242.40 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000354180B9476080459B05E1BF834B446F070034AD76187591974DBF6C4F76951C873A01000200000000002495DA25D80D98438130990BFAFE78050000000007FA0000143C62F6803C4E4D988C1456296B6D08 X-MS-Has-Attach: X-MS-TNEF-Correlator: X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|23010399003|366016|39142699007|31052699007|11063799006|4143699003|56012099006|260925021311599003|260925022911599003|260925021911599003|261009223027099003|10067099003|22082099003|55112099003|18002099003|8096899003|41050700001; X-Microsoft-Antispam-Message-Info-Original: tJbQu37W7xxfb8fE8Kj7I7sD7anPbRLDTdniMkeUoW1SrDRo+s0ACBTsXJqnH3KtQOqZnmhgh7B+oe2cO+GYshSuzkoDQVLyvxplbPjd7iIMhWM7JHgRPdxM53K7Wp+bF7wjXIij/nELq/2N5LRF7/MtvACY8dTot4DV3z3KmU0SvgKbc5HUGtZ1ZvJ4m4DLPxxp2q9pebYFwmaflkge/4++MkeJ6Y5yZfasjh4hafaGE/rlXPDwCWUPbCBHTTdzgzxuSFGAxSIGcvgWi+lyyMnXw+e4t7s8VjHQ9V0TQZIYsTzaqk1+6Yc2uhVjPnX34dNO998GmJepKoUC+vQvUS6LiLCXPMhEufEV6B9U/v0bKMImkVEcoU7BqHenFR7BGZydQmwGYiGIaUZWHWxIBHqtjmTmMy9tQmH33Fx1OF0NWUz1F62LbR+MZ5x7/EY2qZvJyybGfnSxfTFy/Xyq+3vQG2cg9wjL6ehwQC+xw3/rPQL148M0/RxM6lusckw5kylFfCYez4IiuVlOGqKxafhc4U2jj0kRQBhYzuhQslfJe6cZRzUfRxTeJ9XOUrReCc29HjsCG4fgirB30eeO7LkFVgEyxRCr9Co4NVXcTGI3COytHXECxe5sDmegLJW02x7mWYZVt9OUAWsiSn228reYwR1inJNzEbll6Jlebk8jkbwghQLmXX2sVvW2zyar X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV2PR02MB11921.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(23010399003)(366016)(39142699007)(31052699007)(11063799006)(4143699003)(56012099006)(260925021311599003)(260925022911599003)(260925021911599003)(261009223027099003)(10067099003)(22082099003)(55112099003)(18002099003)(8096899003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: L8b3rryGixPTx6uCMUMqc/EtI9YKLyVqiy3thb9EVnwgLihZF1MRzMTvSl5j7UX7ZJLf+CUOvOS8FHqsPe/0EvSRSPvV3a4btVHCtR6sqZk6hpgUn3tAF6dIuj+zBww33TtPLG1quKeggRkFwkxOnjI2gwCp+Ejrr/TtN7a26bNyFw4yijG5SuH7Oa1cyfupPq5blhoBcSpxiceklId/Lw+TvCYFLGbiQ2Mzl2iZ4Hr1BFaSKEwGGtxbHHsGZrg4HmWeqYPMouvFNqcU2zSN6s+oO1AKeQiePCygr0EMw/MNg9FeTsJ1SMdAHvlwO77V/MhPWhduD+mUkh2Rh1ZJ1g== X-OrganizationHeadersPreserved: PAVPR02MB9596.eurprd02.prod.outlook.com X-CodeTwo-MessageID: e62b8fac-2532-43e3-8af0-0e6d1fdee240.20261014062757@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-CrossPremisesHeadersPromoted: AM7PEPF00000054.EURPRD83.prod.outlook.com X-CrossPremisesHeadersFiltered: AM7PEPF00000054.EURPRD83.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: AM7PEPF00000054.EURPRD83.prod.outlook.com X-OriginatorOrg: eegovg01.onmicrosoft.com X-MS-Office365-Filtering-Correlation-Id-Prvs: 74de7dad-af59-4075-3cd9-08df29bc4881 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] acceptlanguage: en-GB, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-10-14T06:27:54.883Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; authentication-results-original: mx.microsoft.com 1; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; This is a multipart message in MIME format. ------=_NextPart_000_02A3_01DD5CA6.CA399200 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit _____ Saatja: Anete Loreen Saar Saadetud: esmaspäev, 12. oktoober 2026 15:47 Adressaat: Carmen Katariina Sikk - RA Teema: Apteekide tulevik ja proviisorite järelkasv Viljandimaal Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Kirjutan Teile Viljandimaa ajalehest Sakala. Koostan lugu Viljandimaa väikelinnade ja maapiirkondade apteekide tulevikust, keskendudes eelkõige proviisorite ja farmatseutide järelkasvule ning apteegiteenuse kättesaadavusele väiksemates asulates. Teema ajendiks on juba mitmendat korda nähtav Võhma apteegi ajutine sulgemine apteekri puhkuse tõttu. Soovime uurida, kui sõltuvad on väiksemad apteegid üksikutest töötajatest, kas neisse piirkondadesse leidub piisavalt uusi spetsialiste ning millised on apteegiteenuse säilimise väljavaated. Palun võimalusel vastata järgmistele küsimustele. 1. Kui palju tegutseb praegu Viljandimaal apteeke ning kuidas on nende arv viimase kümne aasta jooksul muutunud? Millistes asulates on apteeke suletud? 2. Kui palju töötab Viljandimaa apteekides proviisoreid ja farmatseute ning milline on nende vanuseline jaotus? Kas on teada, kui suur osa neist jõuab lähima viie kuni kümne aasta jooksul pensioniikka? 3. Kas Ravimiameti hinnangul on väiksemates asulates proviisorite ja farmatseutide puudus probleem? Kas Viljandimaal on viimastel aastatel tulnud apteeke töötajate puudumise tõttu ajutiselt või lõplikult sulgeda? 4. Kui väikelinna ainus apteek jääb töötajata või selle pidamine muutub majanduslikult kahjumlikuks, siis millised võimalused on apteegiteenuse säilitamiseks? Kas riigil on selleks toetusi või muid meetmeid? Kõike head, Anete Loreen Saar Sakala +372 433 0054 aneteloreen.saar@ajaleht.ee ------=_NextPart_000_02A3_01DD5CA6.CA399200 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable


Saatja: Anete Loreen Saar <aneteloreen.saar@ajaleht.ee>
Saadetud: esmasp=C3=A4ev, 12. oktoober 2026 15:47
Adressaat: Carmen Katariina Sikk - RA = <carmenkatariina.sikk@ravimiamet.ee>
Teema: Apteekide tulevik ja proviisorite j=C3=A4relkasv = Viljandimaal
 

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere!
Kirjutan Teile Viljandimaa ajalehest Sakala. Koostan lugu Viljandimaa = v=C3=A4ikelinnade ja maapiirkondade apteekide tulevikust, keskendudes = eelk=C3=B5ige proviisorite ja farmatseutide j=C3=A4relkasvule ning = apteegiteenuse k=C3=A4ttesaadavusele v=C3=A4iksemates asulates.
Teema ajendiks on juba mitmendat korda n=C3=A4htav V=C3=B5hma apteegi = ajutine sulgemine apteekri puhkuse t=C3=B5ttu. Soovime uurida, kui = s=C3=B5ltuvad on v=C3=A4iksemad apteegid =C3=BCksikutest = t=C3=B6=C3=B6tajatest, kas neisse piirkondadesse leidub piisavalt uusi = spetsialiste ning millised on apteegiteenuse s=C3=A4ilimise v=C3=A4ljavaated.
Palun v=C3=B5imalusel vastata j=C3=A4rgmistele k=C3=BCsimustele.
  1. Kui palju tegutseb = praegu Viljandimaal apteeke ning kuidas on nende arv viimase k=C3=BCmne = aasta jooksul muutunud? Millistes asulates on apteeke suletud?
  2. Kui palju = t=C3=B6=C3=B6tab Viljandimaa apteekides proviisoreid ja farmatseute ning = milline on nende vanuseline jaotus? Kas on teada, kui suur osa neist = j=C3=B5uab l=C3=A4hima viie kuni k=C3=BCmne aasta jooksul = pensioniikka?
  3. Kas Ravimiameti = hinnangul on v=C3=A4iksemates asulates proviisorite ja farmatseutide = puudus probleem? Kas Viljandimaal on viimastel aastatel tulnud apteeke = t=C3=B6=C3=B6tajate puudumise t=C3=B5ttu ajutiselt v=C3=B5i = l=C3=B5plikult sulgeda?
  4. Kui v=C3=A4ikelinna = ainus apteek j=C3=A4=C3=A4b t=C3=B6=C3=B6tajata v=C3=B5i selle pidamine = muutub majanduslikult kahjumlikuks, siis millised v=C3=B5imalused on = apteegiteenuse s=C3=A4ilitamiseks? Kas riigil on selleks toetusi = v=C3=B5i muid meetmeid?

K=C3=B5ike head,

Anete Loreen = Saar

Sakala
+372 433 0054

aneteloreen.saar@ajaleht.ee


------=_NextPart_000_02A3_01DD5CA6.CA399200--